title: Cyclosporine dosage according to pharmacokinetic profiles leads to better graft and patient survival rates and a decrease in cyclosporine consumption.
authors.affiliation: Emirates Institute of Medical Research, Abu Dhabi, United Arab Emirates.
authors.forename: M A
authors.initials: MA
authors.lastname: Masri
authors.forename: V S
authors.initials: VS
authors.lastname: Dhawan
authors.forename: K
authors.initials: K
authors.lastname: Hayes
authors.forename: T
authors.initials: T
authors.lastname: Karim
authors.forename: A
authors.initials: A
authors.lastname: Pingle
mesh_terms: D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D011239:Prednisolone / Q000627:therapeutic use; D016019:Survival Analysis
chemical_list: D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine